A carregar...
Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis
BACKGROUND: Ipilimumab and Nivolumab, targeting the molecules CTLA-4, PD-1, respectively,have shown efficacy against several types of cancer. Despite these results, only a small percentage of patients maintains a long-lasting effect. Even Ipilimumab, in combination with nivolumab, has demonstrated a...
Na minha lista:
| Publicado no: | J Transl Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688006/ https://ncbi.nlm.nih.gov/pubmed/33239030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02588-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|